Skip to main content

Hypertension in the Very Old: Special Features, Therapeutic Approaches, and Problems

  • Chapter
  • First Online:
Special Issues in Hypertension

Abstract

Systolic hypertension is a common condition in the elderly and is considered a major determinant not only of cardiovascular morbidity and mortality, but also cognitive decline, frailty and loss of autonomy. We have now evidence that in community living hypertensive subjects over 80 years old, decreasing blood pressure with pharmacological treatment is able to reduce the rate of cardiovascular events and total mortality. By contrast the efficacy of this treatment in preventing dementia is more controversial. A systolic BP of 150 mmHg is an acceptable cut-off value both for the diagnosis of hypertension and as a target for treatment in most patients >80 years old. To avoid over-treating, it is important to confirm the diagnosis with blood pressure monitoring at home. Treatment should be initiated and followed up in a shared decision making process, taking the patients’ preferences into account. The risk of drug-induced orthostatic hypotension should always be taken into account but should rarely be a reason not to treat. Avoiding “going too low” is important not only at the initiation of therapy, but also during follow-up. Prospectively, other than blood pressure values could better evaluate the age-related arterial alterations especially in the very elderly frail subjects. In this respect, assessment of arterial stiffness could provide significant new information in order to estimate the risk and evaluate the potential benefits of treatment in the very elderly.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lakatta EG, Levy D (2003) Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a “set up” for vascular disease. Circulation 107:139–146

    Article  PubMed  Google Scholar 

  2. Franklin SS, Gustin WIV, Wong ND et al (1997) Hemodynamic patterns of age-related changes in blood pressure: the framingham heart study. Circulation 96:308–315

    Article  PubMed  CAS  Google Scholar 

  3. Benetos A, Salvi P, Lacolley P (2011) Blood pressure regulation during the aging process: the end of the ‘hypertension era’? J Hypertens 29:646–652

    Article  PubMed  CAS  Google Scholar 

  4. Staessen JA, Fagard R, Thijs L et al (1997) Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The systolic hypertension in Europe (Syst-Eur) trial investigators. Lancet 350:757–764

    Article  PubMed  CAS  Google Scholar 

  5. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension (1991) Final results of the systolic hypertension in the elderly program (SHEP). SHEP cooperative research group. JAMA 265:3255–3264

    Google Scholar 

  6. Beckett NS, Peters R, Fletcher AE et al (2008) Treatment of hypertension in patients 80 years of age or older. N Engl J Med 358:1887–1898

    Article  PubMed  CAS  Google Scholar 

  7. Vyssoulis G, Karpanou E, Adamopoulos D et al (2011) Effect of age on interdependence and hierarchy of cardiovascular risk factors in hypertensive patients. Am J Cardiol 108:240–245

    Article  PubMed  Google Scholar 

  8. Fagard RH, Staessen JA, Thijs L et al (2000) Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic hypertension in Europe (Syst-Eur) trial investigators. Circulation 102:1139–1144

    Article  PubMed  CAS  Google Scholar 

  9. Aronow WS, Fleg JL, Pepine CJ et al (2011) ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American college of cardiology foundation task force on clinical expert consensus documents developed in collaboration with the American academy of neurology, American geriatrics society, American society for preventive cardiology, American society of hypertension, American society of nephrology, association of black cardiologists, and European society of hypertension. J Am Coll Cardiol 57:2037–2114

    Article  PubMed  Google Scholar 

  10. The ACCORD Study Group (2010) Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 362:1575–1585

    Article  Google Scholar 

  11. Budnitz DS, Lovegrove MC, Shehab N, Richards CL (2011) Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 365:2002–2012

    Article  PubMed  CAS  Google Scholar 

  12. Alberti KG, Zimmet P, Shaw J (2006) Metabolic syndrome–a new world-wide definition. A consensus statement from the international diabetes federation. Diabetes Med 23:469–480

    Article  CAS  Google Scholar 

  13. The Diabetes Prevention Program Research Group (2005) Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program. Diabetes Care 28:888–894

    Article  Google Scholar 

  14. Thomas F, Pannier B, Benetos A, Vischer UM (2011) The impact of the metabolic syndrome—but not of hypertension—on all-cause mortality disappears in the elderly. J Hypertens 29:663–668

    Article  PubMed  CAS  Google Scholar 

  15. Wang J, Ruotsalainen S, Moilanen L et al (2007) The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns. Eur Heart J 28:857–864

    Article  PubMed  Google Scholar 

  16. Salminen M, Kuoppamaki M, Vahlberg T et al (2010) The metabolic syndrome defined by modified international diabetes federation criteria and mortality: a 9-year follow-up of the aged in Finland. Diabetes Metab 36:437–442

    Article  PubMed  CAS  Google Scholar 

  17. Stevens J, Cai J, Pamuk ER et al (1998) The effect of age on the association between body-mass index and mortality. N Engl J Med 338:1–7

    Article  PubMed  CAS  Google Scholar 

  18. Vischer UM, Safar ME, Safar H et al (2009) Cardiometabolic determinants of mortality in a geriatric population: is there a “reverse metabolic syndrome”? Diabetes Metab 35:108–114

    Article  PubMed  CAS  Google Scholar 

  19. Janssen I, Katzmarzyk PT, Ross R (2005) Body mass index is inversely related to mortality in older people after adjustment for waist circumference. J Am Geriatr Soc 53:2112–2118

    Article  PubMed  Google Scholar 

  20. Curb JD, Pressel SL, Cutler JA et al (1996) Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic hypertension in the elderly program cooperative research group. JAMA 276:1886–1892

    Article  PubMed  CAS  Google Scholar 

  21. Tuomilehto J, Rastenyte D, Birkenhager WH et al (1999) Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic hypertension in Europe trial investigators. N Engl J Med 340:677–684

    Article  PubMed  CAS  Google Scholar 

  22. Vischer UM, Bauduceau B, Bourdel-Marchasson I et al (2009) A call to incorporate the prevention and treatment of geriatric disorders in the management of diabetes in the elderly. Diabetes Metab 35:168–177

    Article  PubMed  Google Scholar 

  23. Laurent S, Cockcroft J, Van Bortel L et al (2006) Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 27:2588–2605

    Article  PubMed  Google Scholar 

  24. Masaki KH, Schatz IJ, Burchfiel CM et al (1998) Orthostatic hypotension predicts mortality in elderly men: the Honolulu heart program. Circulation 98:2290–2295

    Article  PubMed  CAS  Google Scholar 

  25. Rutan GH, Hermanson B, Bild DE et al. (1992) Orthostatic hypotension in older adults. The cardiovascular health study. CHS collaborative research group. Hypertension 19:508–519

    Google Scholar 

  26. Valbusa F, Labat C, Salvi P et al (2012) Orthostatic hypotension in very old individuals living in nursing homes: the PARTAGE study. J Hypertens 30:53–60

    Article  PubMed  CAS  Google Scholar 

  27. Lipsitz LA (1989) Orthostatic hypotension in the elderly. N Engl J Med 321:952–957

    Article  PubMed  CAS  Google Scholar 

  28. Mattace-Raso FU, van der Cammen TJ, Knetsch AM et al (2006) Arterial stiffness as the candidate underlying mechanism for postural blood pressure changes and orthostatic hypotension in older adults: the Rotterdam study. J Hypertens 24:339–344

    Article  PubMed  CAS  Google Scholar 

  29. Kamaruzzaman S, Watt H, Carson C, Ebrahim S (2010) The association between orthostatic hypotension and medication use in the British women’s heart and health study. Age Ageing 39:51–56

    Article  PubMed  Google Scholar 

  30. Woolcott JC, Richardson KJ, Wiens MO et al (2009) Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 169:1952–1960

    Article  PubMed  Google Scholar 

  31. Elias MF, Wolf PA, D’Agostino RB et al (1993) Untreated blood pressure level is inversely related to cognitive functioning: the Framingham study. Am J Epidemiol 138:353–364

    PubMed  CAS  Google Scholar 

  32. Launer LJ, Ross GW, Petrovitch H et al (2000) Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging 21:49–55

    Article  PubMed  CAS  Google Scholar 

  33. Skoog I, Lernfelt B, Landahl S et al (1996) 15-year longitudinal study of blood pressure and dementia. Lancet 347:1141–1145

    Article  PubMed  CAS  Google Scholar 

  34. Tzourio C, Dufouil C, Ducimetiere P, Alperovitch A (1999) Cognitive decline in individuals with high blood pressure: a longitudinal study in the elderly. EVA study group. Epidemiology of vascular aging. Neurology 53:1948–1952

    Article  PubMed  CAS  Google Scholar 

  35. Desmond DW, Tatemichi TK, Paik M, Stern Y (1993) Risk factors for cerebrovascular disease as correlates of cognitive function in a stroke-free cohort. Arch Neurol 50:162–166

    Article  PubMed  CAS  Google Scholar 

  36. Di Carlo A, Baldereschi M, Amaducci L et al (2000) Cognitive impairment without dementia in older people: prevalence, vascular risk factors, impact on disability. The Italian longitudinal study on aging. J Am Geriatr Soc 48:775–782

    PubMed  Google Scholar 

  37. Watfa G, Rossignol P, Kearney-Schwartz A et al (2010) Use of calcium channel blockers is associated with better cognitive performance in older hypertensive patients with subjective memory complaints. J Hypertens 28:2485–2493

    Article  PubMed  CAS  Google Scholar 

  38. Forette F, Seux ML, Staessen JA et al (2002) The prevention of dementia with antihypertensive treatment: new evidence from the systolic hypertension in Europe (Syst-Eur) study. Arch Intern Med 162:2046–2052

    Article  PubMed  Google Scholar 

  39. Tzourio C, Anderson C, Chapman N et al (2003) Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 163:1069–1075

    Article  PubMed  CAS  Google Scholar 

  40. Lithell H, Hansson L, Skoog I et al (2003) The study on cognition and prognosis in the elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens 21:875–886

    Article  PubMed  CAS  Google Scholar 

  41. McGuinness B, Todd S, Passmore P, Bullock R (2009) Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Datab Syst Rev (4):CD004034

    Google Scholar 

  42. Peters R, Beckett N, Forette F et al (2008) Incident dementia and blood pressure lowering in the Hypertension in the very elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol 7:683–689

    Article  PubMed  CAS  Google Scholar 

  43. Peters R, Beckett N, Beardmore R et al (2010) Modelling cognitive decline in the Hypertension in the very elderly trial [HYVET] and proposed risk tables for population use. PLoS ONE 5:e11775

    Article  PubMed  Google Scholar 

  44. Benetos A, Watfa G, Hanon O et al (2012) Pulse wave velocity is associated with 1-year cognitive decline in the elderly older than 80 years: the PARTAGE study. J Am Med Dir Assoc 13:239–243

    Google Scholar 

  45. Kearney-Schwartz A, Rossignol P, Bracard S et al (2009) Vascular structure and function is correlated to cognitive performance and white matter hyperintensities in older hypertensive patients with subjective memory complaints. Stroke 40:1229–1236

    Article  PubMed  Google Scholar 

  46. Perret-Guillaume C, Genet C, Herrmann FR et al (2011) Attitudes and approaches to decision making about antihypertensive treatment in elderly patients. J Am Med Dir Assoc 12:121–128

    Article  PubMed  Google Scholar 

  47. Langer RD, Ganiats TG, Barrett-Connor E (1989) Paradoxical survival of elderly men with high blood pressure. BMJ 298:1356–1357

    Article  PubMed  CAS  Google Scholar 

  48. van Hateren KJJ, Landman GWD, Kleefstra N et al (2010) Lower blood pressure associated with higher mortality in elderly diabetic patients (ZODIAC-12). Age Ageing 39:603–609

    Article  PubMed  Google Scholar 

  49. Rönnback M, Isomaa B, Fagerudd J et al (2006) Complex relationship between blood pressure and mortality in type 2 diabetic patients. Hypertension 47:168–173

    Article  PubMed  Google Scholar 

  50. Boshuizen HC, Izaks GJ, van Buuren S, Ligthart GJ (1998) Blood pressure and mortality in elderly people aged 85 and older: community based study. BMJ 316:1780–1784

    Article  PubMed  CAS  Google Scholar 

  51. Satish S, Zhang DD, Goodwin JS (2001) Clinical significance of falling blood pressure among older adults. J Clin Epidemiol 54:961–967

    Article  PubMed  CAS  Google Scholar 

  52. Rogers MAM, Ward K, Gure TR et al (2011) Blood pressure trajectories prior to death in patients with diabetes. Diabetes Care 34:1534–1539

    Article  PubMed  Google Scholar 

  53. Greenfield JR, Miller JW, Keogh JM et al (2009) Modulation of blood pressure by central melanocortinergic pathways. N Engl J Med 360:44–52

    Article  PubMed  CAS  Google Scholar 

  54. Messerli FH, Mancia G, Conti CR et al (2006) Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med 144:884–893

    PubMed  Google Scholar 

  55. Benetos A, Buatois S, Salvi P et al (2010) Blood pressure and pulse wave velocity values in the institutionalized elderly aged 80 and over: baseline of the PARTAGE study. J Hypertens 28:41–50

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Athanase Benetos .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Italia

About this chapter

Cite this chapter

Benetos, A., Vischer, U.M., Watfa, G. (2012). Hypertension in the Very Old: Special Features, Therapeutic Approaches, and Problems. In: Berbari, A., Mancia, G. (eds) Special Issues in Hypertension. Springer, Milano. https://doi.org/10.1007/978-88-470-2601-8_5

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2601-8_5

  • Published:

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-2600-1

  • Online ISBN: 978-88-470-2601-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics